UPDATED: Investors punished Synlait Milk [NZX: SML] shares after the dairy processor was forced to wind back the bullish profit forecast it gave in January because of disruptions from increased Chinese regulations on infant formula and unfavourable foreign exchange movements.
The stock dropped 7.3 percent to a three-week low of $3.70, trimming their gains from last year's initial public offering to 68 percent. The full-year profit forecast was cut to a range of $25 million to $30 million, down from the $30 million-to-$35 million estimate given in January, Synlait said today.
"In January we under-estimated the full impact," managing director John Penno told BusinessDesk. "The Chinese regulations had been signalled for some time but what's become apparent since December is how fast they are going to move."
"Whenever changes of this magnitude happen, various companies start standing back and not committing to powder," he said.
In December, China's State Food and Drug Administration unveiled revised regulations covering product safety control, purchase of raw materials, formula product inspection, manufacturing process and product traceability for infant formula, the state newswire Xinhua reported at the time. The changes are part of China's response to the tainted milk scandal in 2008 which left six babies dead, sickened 300,000 and damaged confidence in Chinese dairy products.
Under the revised rules primary liability for infant formula is sheeted home to the producers, who must comply with new licensing rules and register their formula, packaging and labels with provincial authorities. Producers must also have systems in place for product recalls.
Infant formula is a key market for Synlait, which projects sales into that sector will account for 30 percent of total product sold in 2015. Sales in the current year are now expected to be similar to 2013 and the company took a pretax provision of $5.8 million against its first half results to write down infant and nutritional inventories.
Synlait also disclosed a pretax cost of about $3.6 million for unfavourable foreign exchange rates compared to those it used to set its farm gate milk price, which it expects will be at a record this year.
"Investor expectations were pretty high," said Grant Williamson, a director at brokerage Hamilton Hindin Greene. "The guidance got a little bit ahead of itself. A number of factors were outside the company's control."
Still, the Chinese formula market "has huge potential" and long term, "it still looks very exciting for the company," he said. The shares had been trading "on relatively high fundamentals" running into today's announcement.
Synlait had warned in January that it may fall short of its target of selling 10,000 metric tonnes of infant formula and nutritional products in China because of disruptions in that market caused by increased regulation.
The company's full-year profit guidance is still well above its prospectus forecast of $19.8 million and Synlait said today it will bring forward some capital spending and make its second infant formula and nutritional spray drier 25 percent larger than had been planned. Most of its production is contract manufacturing either of fully made up and packaged products or ingredients that are then blended by customers and sold under their own brands.
The company is 39 percent owned by China's Bright Dairy & Food. It won't pay a dividend.
EARLIER: Synlait Milk [NZX: SML], whose shares are up 81 percent from its initial public offering, lowered its full-year profit forecast, saying regulatory changes in China and Fonterra Cooperative Group's whey protein recall are denting volumes of infant formula and nutritional products.
Full-year profit will be in a range of $25 million to $30 million, down from the $30 million-to-$35 million estimate it gave in January. The projection is still well ahead of its prospectus forecast of $19.8 million.
The Rakaia-based company lowered its guidance while announcing a 79 percent jump in first-half profit to $12.1 million as sales rose 62 percent to $284.9 million. Its profit margin rose to $919 per metric tonne in the six months ended Jan. 31 from $751 in full-year 2013.
"Despite it being clear that we will not meet our infant formula and nutritional volume targets for this financial year, we remain confident of meeting our long-term objectives," managing director John Penno said in a statement.
"With a favourable product mix and an increasing amount of product sold into value-added applications we expect our milk powder and cream products business to outperform our initial public offer projections in FY2014," he said.
The shares last traded at $3.99, valuing the company at about $584 million. The company is 39 percent owned by China's Bright Dairy & Food. It won't pay a dividend.
Synlait had warned in January that it may fall short of its target of selling 10,000 metric tonnes of infant formula and nutritional products in China because of disruptions in that market caused by increased regulation. Full-year infant formula sales are now expected to be similar to 2013 and the company took a pretax provision against infant and nutritional inventories of $5.8 million.
Overall sales volumes for ingredients rose 4.1 percent to 40,503 metric tonnes in the first half while nutritional volumes jumped about 90 percent to 3,005 tonnes. Total milk procurement rose 7 percent to 31,547 kilograms of milk solids.
The company plans to bring forward some planned capital spending and has increased the capacity of its second infant formula and nutritional spray drier by 25 percent, lifting the cost of the project by $31.5 million to $135 million including site work for a fourth spray drier, it said.
This article is tagged with the following keywords. Find out more about MyNBR Tags
- AngelEquity launches with three investment offers
- Receiver close to Atmospheric sale
- Editor's Insight: How the candidates fared in the first presidential debate
- 'Real housewife' lawyers up, accuses Devoy of bullying, defamation
- Sky will take a gamble and put Westworld, aka 'the next Game of Thrones' on Neon
Most listened to
- No knockout blows in first presidential debate, says NBR's Nevil Gibson
- Intueri's problems raise questions for the board, says Martin Watson of the Shareholders Association
- ANZ's Philip Borkin and NBR's Jason Walls on what's next for the kiwi dollar on Currency Talk
- AngelEquity's Bill Murphy on why his platform won't cater for retail investors
- Spark exec Jason Paris defends his company's honour after it tops ComCom's most-complained-about list
- FMA lawyer Justin Smith counters the Goldman Sachs defence